{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T04:09:11Z","timestamp":1751602151980,"version":"3.41.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.gofs.2018.03.011","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T12:57:06Z","timestamp":1523451426000},"page":"497-502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["M\u00e9tastases p\u00e9riton\u00e9ales microscopiques des cancers \u00e9pith\u00e9liaux de l\u2019ovaire. Pertinence clinique, outils diagnostiques et th\u00e9rapeutiques"],"prefix":"10.1016","volume":"46","author":[{"given":"Y.","family":"Kerbage","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Canlorbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"Estevez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Grabarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Mordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Uzan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Collinet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Aza\u00efs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.gofs.2018.03.011_bib0375","article-title":"Optimal primary surgical treatment for advanced epithelial ovarian cancer","author":"Elattar","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.gofs.2018.03.011_bib0380","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ygyno.2006.03.051","article-title":"What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?","volume":"103","author":"Chi","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2018.03.011_bib0385","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ygyno.2012.02.024","article-title":"Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: Redefining \u201coptimal\u201d residual disease","volume":"125","author":"Chang","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.gofs.2018.03.011_bib0390","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2018.03.011_bib0395","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2009.03.018","article-title":"Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm","volume":"114","author":"Chi","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2018.03.011_bib0400","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ygyno.2012.02.024","article-title":"Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: redefining \u00ab\u00a0optimal\u00a0\u00bb residual disease","volume":"125","author":"Chang","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"12","key":"10.1016\/j.gofs.2018.03.011_bib0405","first-page":"1175","article-title":"[Towards a new standard in cytoreductive surgery for advanced ovarian cancer]","volume":"96","author":"Querleu","year":"2009","journal-title":"Bull Cancer"},{"issue":"2","key":"10.1016\/j.gofs.2018.03.011_bib0410","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4251\/wjgo.v2.i2.102","article-title":"Peritoneal carcinosis of ovarian origin","volume":"2","author":"Fagotti","year":"2010","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.gofs.2018.03.011_bib0415","first-page":"CD008765","article-title":"Surgical cytoreduction for recurrent epithelial ovarian cancer","volume":"2","author":"Al Rawahi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.gofs.2018.03.011_bib0420","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1470-2045(06)70939-1","article-title":"Mechanisms of transcoelomic metastasis in ovarian cancer","volume":"7","author":"Tan","year":"2006","journal-title":"Lancet Oncol"},{"issue":"9951","key":"10.1016\/j.gofs.2018.03.011_bib0425","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","article-title":"Ovarian cancer","volume":"384","author":"Jayson","year":"2014","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.gofs.2018.03.011_bib0430","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/annonc\/mdw306","article-title":"Global trends and predictions in ovarian cancer mortality","volume":"27","author":"Malvezzi","year":"2016","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2018.03.011_bib0435","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.suronc.2017.01.001","article-title":"Dealing with microscopic peritoneal metastases of epithelial ovarian cancer. A surgical challenge","volume":"26","author":"Aza\u00efs","year":"2017","journal-title":"Surg Oncol"},{"issue":"9","key":"10.1016\/j.gofs.2018.03.011_bib0440","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1097\/IGC.0000000000000007","article-title":"Ovarian cancer: sites of recurrence","volume":"23","author":"Amate","year":"2013","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.gofs.2018.03.011_bib0445","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.1525-1438.1995.05050346.x","article-title":"Intestinal obstruction in patients with advanced ovarian cancer","volume":"5","author":"Bais","year":"1995","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.gofs.2018.03.011_bib0450","first-page":"213","article-title":"Analysis of failures and clinical outcome of advanced epithelial ovarian cancer in patients with microscopic residual disease at second-look reassessment following primary cytoreductive surgery and first-line platinum-based chemotherapy","volume":"34","author":"Gadducci","year":"2013","journal-title":"Eur J Gynaecol Oncol"},{"issue":"7","key":"10.1016\/j.gofs.2018.03.011_bib0455","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/IGC.0b013e31822127cd","article-title":"The utility of peritoneal biopsy and omentectomy in the upstaging of apparent early ovarian cancer","volume":"21","author":"Shroff","year":"2011","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.gofs.2018.03.011_bib0460","doi-asserted-by":"crossref","first-page":"81e1","DOI":"10.1016\/j.ajog.2006.08.043","article-title":"Occult metastasis in early ovarian cancers: risk factors and associated prognosis","volume":"196","author":"Ayhan","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.gofs.2018.03.011_bib0465","first-page":"949","article-title":"Comprehensive restaging laparotomy in women with apparent early ovarian carcinoma","volume":"80","author":"Soper","year":"1992","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2018.03.011_bib0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.08.022","article-title":"Is comprehensive surgical staging needed for thorough evaluation of early-stage ovarian carcinoma?","volume":"206","author":"Garcia-Soto","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2018.03.011_bib0475","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ygyno.2009.06.037","article-title":"Random peritoneal biopsies have limited value in staging of apparent early stage epithelial ovarian cancer after thorough exploration","volume":"115","author":"Powless","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.gofs.2018.03.011_bib0480","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1245\/s10434-014-3648-z","article-title":"The role of omentectomy and random peritoneal biopsies as part of comprehensive surgical staging in apparent early-stage epithelial ovarian cancer","volume":"21","author":"Lee","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.gofs.2018.03.011_bib0485","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00276-008-0456-9","article-title":"Peritoneal surface area: measurements of 40 structures covered by peritoneum: correlation between total peritoneal surface area and the surface calculated by formulas","volume":"31","author":"Albanese","year":"2009","journal-title":"Surg Radiol Anat"},{"key":"10.1016\/j.gofs.2018.03.011_bib0490","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejogrb.2017.07.002","article-title":"Dynamic real-time in vivo confocal laser endomicroscopy of the fallopian tube during laparoscopy in the prevention of ovarian cancer","volume":"216","author":"Chene","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.gofs.2018.03.011_bib0495","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pdpdt.2015.07.006","article-title":"Targeted approaches and innovative illumination solutions: a new era for photodynamic therapy applications in gynecologic oncology?","author":"Aza\u00efs","year":"2016","journal-title":"Photodiagn Photodyn Ther Mars"},{"issue":"1","key":"10.1016\/j.gofs.2018.03.011_bib0500","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jss.2015.01.009","article-title":"Photodynamic diagnosis for detection of peritoneal carcinomatosis","volume":"195","author":"Almerie","year":"2015","journal-title":"J Surg Res"},{"issue":"11","key":"10.1016\/j.gofs.2018.03.011_bib0505","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/sj.bjc.6600958","article-title":"Photodynamic diagnosis of ovarian cancer using hexaminolaevulinate: a preclinical study","volume":"88","author":"L\u00fcdicke","year":"2003","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/j.gofs.2018.03.011_bib0510","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/cncr.20155","article-title":"Laparoscopic fluorescence detection of ovarian carcinoma metastases using 5-aminolevulinic acid-induced protoporphyrin IX","volume":"100","author":"L\u00f6ning","year":"2004","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.gofs.2018.03.011_bib0515","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1074-3804(98)80080-7","article-title":"In vivo detection of metastatic ovarian cancer by means of 5-aminolevulinic acid-induced fluorescence in a rat model","volume":"5","author":"Hornung","year":"1998","journal-title":"J Am Assoc Gynecol Laparosc"},{"issue":"1","key":"10.1016\/j.gofs.2018.03.011_bib0520","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1006\/gyno.1996.4502","article-title":"In vivo fluorescence detection of ovarian cancer in the NuTu-19 epithelial ovarian cancer animal model using 5-aminolevulinic acid (ALA)","volume":"66","author":"Major","year":"1997","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2018.03.011_bib0525","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1089\/pho.2007.2057","article-title":"Comparison of aminolevulinic acid\u2013and hexylester aminolevulinate\u2013induced protoporphyrin IX fluorescence for the detection of ovarian cancer in a rat model","volume":"25","author":"Regis","year":"2007","journal-title":"Photomed Laser Surg"},{"issue":"1","key":"10.1016\/j.gofs.2018.03.011_bib0530","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1006\/gyno.2002.6793","article-title":"Laparoscopic photodynamic diagnosis of ovarian cancer using 5-aminolevulinic acid in a rat model","volume":"87","author":"Chan","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gofs.2018.03.011_bib0535","doi-asserted-by":"crossref","DOI":"10.1002\/lsm.20302","article-title":"Fluorescence staining of human ovarian cancer tissue following application of 5-aminolevulinic acid: fluorescence microscopy studies","author":"L\u00f6ning","year":"2006","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.gofs.2018.03.011_bib0540","article-title":"Photodynamic diagnosis with 5-aminolevulinic acid for intraoperative detection of peritoneal metastases of ovarian cancer: a feasibility and dose finding study","author":"Hillemanns","year":"2016","journal-title":"Lasers Surg Med"},{"issue":"13","key":"10.1016\/j.gofs.2018.03.011_bib0545","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1245\/s10434-014-3901-5","article-title":"Cytoreductive surgery under aminolevulinic acid-mediated photodynamic diagnosis plus hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from ovarian cancer and primary peritoneal carcinoma: results of a phase I trial","volume":"21","author":"Liu","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.gofs.2018.03.011_bib0550","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/nm.2472","article-title":"Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-(targeting: first in-human results","volume":"17","author":"van Dam","year":"2011","journal-title":"Nat Med"},{"issue":"22","key":"10.1016\/j.gofs.2018.03.011_bib0555","doi-asserted-by":"crossref","first-page":"32144","DOI":"10.18632\/oncotarget.8282","article-title":"Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17","volume":"7","author":"Tummers","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.gofs.2018.03.011_bib0560","first-page":"2929","article-title":"A novel tumor-specific agent for intraoperative near-infrared fluorescence imaging: a translational study in healthy volunteers and patients with ovarian cancer","volume":"22","author":"Hoogstins","year":"2016","journal-title":"Am Assoc Cancer Res"},{"issue":"3","key":"10.1016\/j.gofs.2018.03.011_bib0565","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/path.4536","article-title":"Efficient molecular subtype classification of high-grade serous ovarian cancer","volume":"236","author":"Leong","year":"2015","journal-title":"J Pathol"},{"issue":"18","key":"10.1016\/j.gofs.2018.03.011_bib0570","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1001\/jama.2016.2640","article-title":"Evolving approaches in research and care for ovarian cancers: a report from the national academies of sciences, engineering, and medicine","volume":"315","author":"Levine","year":"2016","journal-title":"JAMA"},{"year":"2016","series-title":"Ovarian cancers: evolving paradigms in research and care","author":"Committee on the State of the Science in Ovarian Cancer Research","key":"10.1016\/j.gofs.2018.03.011_bib0575"},{"issue":"2","key":"10.1016\/j.gofs.2018.03.011_bib0580","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejca.2013.09.024","article-title":"Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases","volume":"50","author":"Elias","year":"2014","journal-title":"Eur J Cancer Oxf Engl"},{"issue":"2","key":"10.1016\/j.gofs.2018.03.011_bib0585","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1245\/s10434-006-9182-x","article-title":"A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei","volume":"14","author":"Yan","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2018.03.011_bib0590","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.soc.2012.07.007","article-title":"Current status and future directions of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer","volume":"21","author":"Helm","year":"2012","journal-title":"Surg Oncol Clin N Am"},{"issue":"12","key":"10.1016\/j.gofs.2018.03.011_bib0595","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00432-009-0667-4","article-title":"Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results","volume":"135","author":"Chua","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2018.03.011_bib0600","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ejso.2010.11.004","article-title":"Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer","volume":"37","author":"Deraco","year":"2011","journal-title":"Eur J Surg Oncol EJSO"},{"issue":"2","key":"10.1016\/j.gofs.2018.03.011_bib0605","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ejogrb.2011.04.036","article-title":"Heterogeneity in patients and methods. A problem for hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in ovarian carcinoma","volume":"158","author":"Cascales","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"10.1016\/j.gofs.2018.03.011_bib0610","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jviscsurg.2014.07.005","article-title":"Hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer","volume":"151","author":"Bakrin","year":"2014","journal-title":"J Visc Surg"},{"issue":"9","key":"10.1016\/j.gofs.2018.03.011_bib0615","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s00268-007-9146-8","article-title":"Cytoreductive surgery and intraperitoneal chemohyperthermia for chemoresistant and recurrent advanced epithelial ovarian cancer: prospective study of 81 patients","volume":"31","author":"Cotte","year":"2007","journal-title":"World J Surg"},{"issue":"6","key":"10.1016\/j.gofs.2018.03.011_bib0620","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ejso.2006.03.011","article-title":"Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced\/recurrent ovarian cancer patients: the experience of National Cancer Institute of Milan","volume":"32","author":"Raspagliesi","year":"2006","journal-title":"Eur J Surg Oncol EJSO"},{"issue":"1","key":"10.1016\/j.gofs.2018.03.011_bib0625","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ygyno.2007.03.019","article-title":"Treatment of ovarian cancer with paclitaxel- or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery","volume":"106","author":"Bae","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2018.03.011_bib0630","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.gofs.2018.03.011_bib0635","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1245\/s10434-014-3599-4","article-title":"Treatment of microscopic disease with hyperthermic intraoperative intraperitoneal chemotherapy after complete cytoreduction improves disease-free survival in patients with stage IIIC\/IV ovarian cancer","volume":"21","author":"Cascales-Campos","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.gofs.2018.03.011_bib0640","first-page":"2178","article-title":"Multicentric initial experience with the use of the pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the management of unresectable peritoneal carcinomatosis","volume":"43","author":"Alyami","year":"2017","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2018.03.011_bib0645","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ygyno.2013.11.022","article-title":"Activity of pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in women with recurrent, platinum-resistant ovarian cancer: preliminary clinical experience","volume":"132","author":"Tempfer","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2018.03.011_bib0650","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12957-016-1008-0","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"14","author":"Girshally","year":"2016","journal-title":"World J Surg Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2018.03.011_bib0655","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.gyobfe.2014.11.012","article-title":"[Pressurized intraperitoneal aerosol chemotherapy (PIPAC): a new way of administration in peritoneal carcinomatosis of ovarian cancer]","volume":"43","author":"Sabaila","year":"2015","journal-title":"Gynecol Obstet Fertil"},{"issue":"6","key":"10.1016\/j.gofs.2018.03.011_bib0660","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.athoracsur.2014.12.077","article-title":"Intrapleural photodynamic therapy for mesothelioma: what place and which future?","volume":"99","author":"Munck","year":"2015","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.gofs.2018.03.011_bib0665","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1470-2045(16)30661-1","article-title":"Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial","volume":"18","author":"Azzouzi","year":"2017","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2018.03.011_bib0670","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0360-3016(93)90066-5","article-title":"Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors","volume":"25","author":"Delaney","year":"1993","journal-title":"Int J Radiat Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2018.03.011_bib0675","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10434-001-0065-x","article-title":"Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors","volume":"8","author":"Hendren","year":"2001","journal-title":"Ann Surg Oncol"},{"issue":"18","key":"10.1016\/j.gofs.2018.03.011_bib0680","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1158\/1078-0432.CCR-06-0953","article-title":"Photofrin uptake in the tumor and normal tissues of patients receiving intraperitoneal photodynamic therapy","volume":"12","author":"Hahn","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.gofs.2018.03.011_bib0685","first-page":"493","article-title":"Intraperitoneal photodynamic therapy","volume":"134","author":"Cengel","year":"2007","journal-title":"Cancer Treat Res"},{"issue":"2","key":"10.1016\/j.gofs.2018.03.011_bib0690","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1078\/0171-2985-00221","article-title":"The immunological consequences of photodynamic treatment of cancer, a literature review","volume":"207","author":"van Duijnhoven","year":"2003","journal-title":"Immunobiology"},{"key":"10.1016\/j.gofs.2018.03.011_bib0695","first-page":"S","article-title":"Photodynamic therapy and antitumor immunity","volume":"1","author":"Gollnick","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"issue":"7","key":"10.1016\/j.gofs.2018.03.011_bib0700","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrc1894","article-title":"Photodynamic therapy and anti-tumour immunity","volume":"6","author":"Castano","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.gofs.2018.03.011_bib0705","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pdpdt.2015.07.005","article-title":"Assessment of the specificity of a new folate-targeted photosensitizer for peritoneal metastasis of epithelial ovarian cancer to enable intraperitoneal photodynamic therapy. A preclinical study","author":"Aza\u00efs","year":"2016","journal-title":"Photodiagnosis Photodyn Ther Mars"},{"issue":"4","key":"10.1016\/j.gofs.2018.03.011_bib0710","first-page":"190","article-title":"[Specific folic-acid targeted photosensitizer. The first step toward intraperitoneal photodynamic therapy for epithelial ovarian cancer]","volume":"45","author":"Aza\u00efs","year":"2017","journal-title":"Gynecol Obstet Fertil Senol"},{"issue":"4","key":"10.1016\/j.gofs.2018.03.011_bib0715","first-page":"249","article-title":"[Intraperitoneal photodynamic therapy for peritoneal metastasis of epithelial ovarian cancer. Limits and future prospects]","volume":"45","author":"Aza\u00efs","year":"2017","journal-title":"Gynecol Obstet Fertil Senol"},{"issue":"1","key":"10.1016\/j.gofs.2018.03.011_bib0720","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pdpdt.2014.11.002","article-title":"Light emitting fabric technologies for photodynamic therapy","volume":"12","author":"Mordon","year":"2015","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"3","key":"10.1016\/j.gofs.2018.03.011_bib0725","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.msec.2012.12.007","article-title":"New design of textile light diffusers for photodynamic therapy","volume":"33","author":"Cochrane","year":"2013","journal-title":"Mater Sci Eng C"},{"issue":"12","key":"10.1016\/j.gofs.2018.03.011_bib0730","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1684\/bdc.2014.1977","article-title":"[FR\u03b1: a target for prophylactic photodynamic therapy of ovarian peritoneal metastasis?]","volume":"101","author":"Aza\u00efs","year":"2014","journal-title":"Bull Cancer"},{"key":"10.1016\/j.gofs.2018.03.011_bib0735","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129766","article-title":"The value of intraoperative near-infrared fluorescence imaging based on enhanced permeability and retention of indocyanine green: feasibility and false-positives in ovarian cancer","author":"Tummers","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.gofs.2018.03.011_bib0370","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.7314\/APJCP.2016.17.4.2271","article-title":"5-Aminolevulinic acid fluorescence in detection of peritoneal metastases","volume":"17","author":"Yonemura","year":"2016","journal-title":"Asian Pac J Cancer Prev APJCP"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718918300916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718918300916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T15:48:10Z","timestamp":1751557690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718918300916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S2468718918300916"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2018.03.011","relation":{},"ISSN":["2468-7189"],"issn-type":[{"type":"print","value":"2468-7189"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"M\u00e9tastases p\u00e9riton\u00e9ales microscopiques des cancers \u00e9pith\u00e9liaux de l\u2019ovaire. Pertinence clinique, outils diagnostiques et th\u00e9rapeutiques","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2018.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}